Patent ID: 9592296
Date: 2017-03-14
CPC Classifications: A61K,A61P

Claim:
1. Pharmaceutical composition for oral administration consisting of: (i) 10 to 30% by weight of simvastatin, (ii) 0.01 to 3% by weight of a first anti-oxidatively active substance (A1) being butylated hydroxyanisole, (iii) 0.01 to 3% by weight of a second anti-oxidatively active substance (A2), different from the first anti-oxidatively active substance (A1), being citric acid, and (iv) 60 to 85% by weight of at least one additive selected from the group consisting of fillers, binders, flow regulating agents, disintegrants, anti-blocking agents, lubricants and combinations thereof, wherein the composition has a weight between 130 milligrams and 300 milligrams up to 300 mg: and wherein the composition is present as a film-coated tablet.